This investigational drug may be helpful for the treatment of respiratory syncytial virus. This study will measure how much of the study drug gets into the blood stream, urine, and stool, and how long it takes the body to eliminate it. Additionally, the safety and tolerability of the study drug will be assessed. You will be given a single oral dose of the study drug.
Check-in: Jun 8
Minimum Check-Out: Jun 13
Maximum Check-Out: Jun 19
Compensation up to $3,330 to $6,060 may be provided for time and participation